The effective study for mechanical vibration and routine bladder perfusion compared with routine bladder perfusion in urinary tract infection caused by neurogenic bladder after spinal cord injury

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025270

Enrollment

Unknown

Registered

2019-08-18

Start date

2019-08-20

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urinary tract infection caused by neurogenic bladder after spinal cord injury

Interventions

Control group:routine bladder perfusion

Intervention group:mechanical vibration and routine bladder perfusion

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Subjects with spinal cord injury confirmed by CT or MRI imaging; 2. Eligible subjects must meet the criteria for neurogenic bladder diagnosis; 3. The included qualified subjects met the diagnostic criteria for urinary tract infection: bacteriuria can be diagnosed when the number of bacteria in each ml of clean midstream urine sample is >= 105 or the number of bacteria is in urine, and the possibility of urinary tract infection should be considered; 4. Eligible subjects were enrolled between the ages of 18 and 80; 5. Qualified subjects enrolled should sign informed consent voluntarily, be able to understand and cooperate with relevant examinations, rehabilitation assessment and treatment.

Exclusion criteria

Exclusion criteria: 1. Life is not stable or/and the illness is serious; 2. Subjects whose bladder volume was too small and the bladder pressure was more than 40cmH2O by simple bladder pressure measurement; 3. The patient is being treated with antibiotics; 4. Patients with severe cognitive impairment who are unable to cooperate with examination, evaluation and treatment; 5. Patients were diagnosed with severe heart disease, heart, liver, renal failure, malignant tumor, gastrointestinal bleeding and so on; 6. Patients who are included in other clinical trials that would affect the evaluation results of this study.

Design outcomes

Primary

Measure	Time frame
Quantitative detection of midstream urinary sediment;Midcourse urine culture;	—

Secondary

Measure	Time frame
Activities of Daily Living;Quality of life;	—

Countries

China

Contacts

Public ContactZhengkun Lin

The 909th Hospital of the Joint Logistic Support Force of PLA

593327953@qq.com+86 13799930329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026